Ping Chi, MD, PhD, is a Member/Professor in the Human Oncology and Pathogenesis Program (HOPP) and an Attending Physician in the Department of Medicine at Memorial Sloan Kettering Cancer Center, and a Professor in the Department of Medicine, Weill Cornell Medical College. She is a graduate of the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program. She completed residency training in Internal Medicine at the Brigham and Woman’s Hospital, Harvard Medical School, fellowship training in Medical Oncology at the Memorial Sloan Kettering Cancer Center, and a concurrent postdoctoral training in epigenetics and chromatin biology in the C. David Allis’ lab at the Rockefeller University. She is an NIH-funded physician-scientist who treats patients with sarcoma and melanoma in the clinic and studies cancer pathogenesis in the laboratory. Her laboratory research has focused on the discovery and understanding of novel genetic and epigenetic mechanisms involved in the cellular context/lineage-specific developmental programs and their contribution to cancer pathogenesis. Through mechanistic studies, she aims to identify novel therapeutic strategies to target oncogenic transcription factors and novel mechanisms of aberrant transcriptional activation of oncogenes. She also maintains an active academic clinical practice, leads early phase clinical trials, and works with a multidisciplinary team to care for patients with melanoma and sarcomas (e.g., GIST, MPNST), with the goal to expedite clinical translation of laboratory research.